US FDA sends warning to Cardinal Health for marketing unapproved devices

(Reuters) – The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.

(Reporting by Pratik Jain in Bengaluru)